Institutional Ownership
Pyxis Oncology Inc
CUSIP 747324101COMMON STOCKPYXSQ1 2026
13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
19.0%
Max % of class reported
Institutional Holders
74
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
36 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | Laurion Capital Management LP | 13G/A | 7.7% | — | SEC |
| 2 | Oct 14, 2025 | Millennium Management LLC | 13G/A | 1.3% | 818.1K | SEC |
| 3 | Sep 23, 2025 | Gordonmd Global Investments LP | 13G | 6.2% | — | SEC |
| 4 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 1.5% | 926.8K | SEC |
| 5 | Jul 1, 2025 | Millennium Management LLC | 13G | 5.7% | 3.54M | SEC |
| 6 | May 6, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 4.0% | 2.49M | SEC |
| 7 | Apr 2, 2025 | Lara Sullivan, M.D. | 13D/A | 11.2% | — | SEC |
| 8 | Feb 14, 2025 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 9 | Feb 14, 2025 | Ridgeback Capital Investments L.P. | 13G/A | 0.6% | 359.2K | SEC |
| 10 | Feb 4, 2025 | Blackrock, Inc. | 13G | 5.6% | 3.34M | SEC |
26 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Pyxis Oncology Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Pfizer Inc | 7.03M | $9.21M |
| 2 | Laurion Capital Management LP | 5.00M | $7.30M |
| 3 | Gordonmd Global Investments LP | 4.12M | $6.02M |
| 4 | Atle Fund Management Ab | 197.0K | $1.62M |
| 5 | Palo Alto Investors LP | 1.01M | $1.48M |
| 6 | 683 Capital Management, LLC | 896.3K | $1.31M |
| 7 | Renaissance Technologies LLC | 888.7K | $1.30M |
| 8 | Blackrock, Inc. | 788.8K | $1.15M |
| 9 | Geode Capital Management, LLC | 598.1K | $873.8K |
| 10 | Longaeva Partners L.P. | 503.2K | $734.7K |